The packaging image may vary depending on the country in which it is marketed.

Logotipo Laboratorios Ovejero
Manufacturer
Laboratorios Ovejero, S.A.
Medicinal product subject to veterinary prescription

MULTICLOS

Inactivated vaccine against clostridiosis, in an injectable suspension
Target species
Cattle icon
Cattle
Sheep icon
Sheep
Goats icon
Goats
Rabbits icon
Rabbits
Composition
Each dose (2 ml) contains:

Active substance:
Clostridium perfringens Type B and A (alpha) 5 UI/ml
Clostridium perfringens Type C (Beta) 10 UI/ml
Clostridium perfringens Type D (Epsilon) 5 UI/ml
Clostridium chauvoei 5 UI/ml
Clostridium novyi Type B 3,5 UI/ml
Clostridium septicum 2,5 UI/ml
Clostridium tetani 2,5 UI/ml

Adjuvant:
Aluminium hydroxide (Al3+)
Formaldehyde
Indications
Active immunisation of cattle, sheep, goats, pigs and rabbits to reduce mortality and clinical symptoms of clostridial processes.
  • Enterotoxemia and gastroenteritis in calves.
  • Haemorrhagic enterotoxemia in sheep.
  • Necrotic enteritis or lamb dysentery (under 15 days).
  • Enterotoxemia in rabbits.
  • Infectious necrotic hepatitis in sheep and goats.
  • Gas gangrene in cattle, goats and sheep.
  • Malignant oedema (Braxy) in cattle.
  • Tetanus
Route of administration
Subcutaneous.
Dosage
  • Sheep and goats: 2 ml/animal at 3–3.5 months of pregnancy. Repeat at the same dose, after 1 month.
  • Lambs and kids (from vaccinated females): 2 ml/animal at 25 days of age.
  • Lambs and kids (from unvaccinated females): 2 ml/animal at 7 days of life.
  • Cattle: 4 ml/animal at 6–7 months of pregnancy. Repeat the same dose, after 1 month.
  • Calves (over 3 months of age): 4 ml/animal. Repeat, 2 ml dose, after 1 month.
  • Calves (under 3 months of age): 3 ml/animal.
  • Rabbits: 1 ml/animal at 15 days of pregnancy.
Vaccination schedule:
Withdrawal period
Zero days.

La imagen puede variar dependiendo del país en el que se comercialice.

Laboratorio fabricante
Laboratorios Ovejero, S.A.
Medicamento sujeto a prescripción veterinaria

MULTICLOS

Inactivated vaccine against clostridiosis, in an injectable suspension
Composición
Each dose (2 ml) contains:

Active substance:
Clostridium perfringens Type B and A (alpha) 5 UI/ml
Clostridium perfringens Type C (Beta) 10 UI/ml
Clostridium perfringens Type D (Epsilon) 5 UI/ml
Clostridium chauvoei 5 UI/ml
Clostridium novyi Type B 3,5 UI/ml
Clostridium septicum 2,5 UI/ml
Clostridium tetani 2,5 UI/ml

Adjuvant:
Aluminium hydroxide (Al3+)
Formaldehyde
Indicaciones
Active immunisation of cattle, sheep, goats, pigs and rabbits to reduce mortality and clinical symptoms of clostridial processes.
  • Enterotoxemia and gastroenteritis in calves.
  • Haemorrhagic enterotoxemia in sheep.
  • Necrotic enteritis or lamb dysentery (under 15 days).
  • Enterotoxemia in rabbits.
  • Infectious necrotic hepatitis in sheep and goats.
  • Gas gangrene in cattle, goats and sheep.
  • Malignant oedema (Braxy) in cattle.
  • Tetanus
Vía de administración
Subcutaneous.
Posología
  • Sheep and goats: 2 ml/animal at 3–3.5 months of pregnancy. Repeat at the same dose, after 1 month.
  • Lambs and kids (from vaccinated females): 2 ml/animal at 25 days of age.
  • Lambs and kids (from unvaccinated females): 2 ml/animal at 7 days of life.
  • Cattle: 4 ml/animal at 6–7 months of pregnancy. Repeat the same dose, after 1 month.
  • Calves (over 3 months of age): 4 ml/animal. Repeat, 2 ml dose, after 1 month.
  • Calves (under 3 months of age): 3 ml/animal.
  • Rabbits: 1 ml/animal at 15 days of pregnancy.
Tiempo de espera
Zero days.
Scroll to Top